{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:13:09Z","timestamp":1758931989321,"version":"3.44.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.npep.2021.102160","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T12:26:51Z","timestamp":1620736011000},"page":"102160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Multiple stage IV colorectal cancers in a patient who received multidisciplinary treatment, including chemotherapy and Japanese Kampo medicine: A case report"],"prefix":"10.1016","volume":"88","author":[{"given":"Naoki","family":"Aomatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutake","family":"Uchima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Matsutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Tsujio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironari","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuma","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeaki","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Nishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Tachimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2021.102160_bb0005","first-page":"3295","article-title":"Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations","volume":"25","author":"Aapro","year":"2017","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.npep.2021.102160_bb0010","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fphar.2015.00150","article-title":"The translational aspect of complementary and alternative medicine for cancer with particular emphasis on Kampo","volume":"6","author":"Amitani","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.npep.2021.102160_bb0015","first-page":"7","article-title":"Postoperative adjuvant chemotherapy regimen of CAPOX combined with ninjin'yoeito in an elderly patient with stage III colon cancer: a case report","author":"Aomatsu","year":"2020","journal-title":"Front. Nutrition"},{"key":"10.1016\/j.npep.2021.102160_bb0020","doi-asserted-by":"crossref","first-page":"779","DOI":"10.7326\/0003-4819-113-10-779","article-title":"Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location","volume":"113","author":"Bufill","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.npep.2021.102160_bb0025","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S1470-2045(15)00122-9","article-title":"FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study","volume":"16","author":"Cremolini","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.npep.2021.102160_bb0030","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/annonc\/mdy140","article-title":"Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO","volume":"29","author":"Cremolini","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.npep.2021.102160_bb0035","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000171605","article-title":"Are right-and left-sided colon neoplasms distinct tumors?","volume":"15","author":"Distler","year":"1997","journal-title":"Dig. Dis."},{"key":"10.1016\/j.npep.2021.102160_bb0040","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(00)02034-1","article-title":"Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial","volume":"355","author":"Douillard","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.npep.2021.102160_bb0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1200\/JCO.2004.09.046","article-title":"A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer","volume":"22","author":"Goldberg","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.npep.2021.102160_bb0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.npep.2019.03.001","article-title":"Ninjin-yoeito activates ghrelin-responsive and unresponsive NPY neurons in the arcuate nucleus and counteracts cisplatin-induced anorexia","volume":"75","author":"Goswami","year":"2019","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2021.102160_bb0055","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ijc.10635","article-title":"Are there two sides to colorectal cancer?","volume":"101","author":"Iacopetta","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.npep.2021.102160_bb0060","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3389\/fphar.2018.00986","article-title":"Gomisin a suppresses colorectal lung metastasis by inducing AMPK\/p38-mediated apoptosis and decreasing metastatic abilities of colorectal cancer cells","volume":"9","author":"Kee","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.npep.2021.102160_bb0065","first-page":"191","article-title":"A traditional chinese herbal medicine, juzen-taiho-to augments the production of granulocyte\/macrophage colony-stimulating factor from human peripheral blood mononuclear cells in vitro","volume":"8","author":"Kubota","year":"1992","journal-title":"Int. J. Immunother."},{"key":"10.1016\/j.npep.2021.102160_bb0070","article-title":"Association of primary (1\u00b0) site and molecular features with progression-free survival (PFS) and overall survival (OS) of metastatic colorectal cancer (mCRC) after anti-epidermal growth factor receptor (\u03b1EGFR) therapy","author":"Lee","year":"2016","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.npep.2021.102160_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00280-015-2767-y","article-title":"Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis","volume":"76","author":"Matsuda","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.npep.2021.102160_bb0080","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/annonc\/mdu275","article-title":"Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features","volume":"25","author":"Missiaglia","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.npep.2021.102160_bb0085","first-page":"401","article-title":"Improvement of host-immunity by adjuvant therapy with juzen-taiho-to for patients with brain tumors. No shinkei geka","volume":"31","author":"Miyagami","year":"2003","journal-title":"Neurol. Surgery"},{"key":"10.1016\/j.npep.2021.102160_bb0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fnut.2018.00093","article-title":"Multifunctional actions of ninjinyoeito, a Japanese Kampo medicine: accumulated scientific evidence based on experiments with cells and animal models, and clinical studies","volume":"5","author":"Miyano","year":"2018","journal-title":"Front. Nutrition"},{"key":"10.1016\/j.npep.2021.102160_bb0095","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00280-003-0585-0","article-title":"Preventive effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer","volume":"51","author":"Mori","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.npep.2021.102160_bb0100","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S2095-4964(17)60347-9","article-title":"Standards of reporting kampo products (STORK) in research articles","volume":"15","author":"Motoo","year":"2017","journal-title":"J. Integrat. Med."},{"key":"10.1016\/j.npep.2021.102160_bb0105","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10147-020-01648-3","article-title":"Prophylactic efficacy of ninjin\u2019yoeito for oxaliplatin-induced cumulative peripheral neuropathy in patients with colorectal cancer receiving postoperative adjuvant chemotherapy: a randomized, open-label, phase 2 trial (HOPE-2)","volume":"25","author":"Motoo","year":"2020","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.npep.2021.102160_bb0110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1349-7006.1998.tb00550.x","article-title":"Oral administration of a Kampo (Japanese herbal) medicine Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma cells","volume":"89","author":"Ohnishi","year":"1998","journal-title":"Jpn. J. Cancer Res.: Gann"},{"key":"10.1016\/j.npep.2021.102160_bb0115","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3389\/fphar.2018.01400","article-title":"Effect of ninjin\u2019yoeito on the loss of skeletal muscle function in cancer-bearing mice","volume":"9","author":"Ohsawa","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.npep.2021.102160_bb0120","first-page":"147","article-title":"A multicenter clinical phase II study of FOLFOXIRI plus bevacizumab as first-line therapy in patients with metastatic colorectal cancer: QUATTRO study","volume":"17","author":"Oki","year":"2018","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.npep.2021.102160_bb0125","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1200\/JCO.2009.22.4295","article-title":"KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial","volume":"27","author":"Richman","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.npep.2021.102160_bb0130","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1248\/bpb.23.677","article-title":"A Kampo medicine \u201cJuzen-taiho-to\u201d--prevention of malignant progression and metastasis of tumor cells and the mechanism of action","volume":"23","author":"Saiki","year":"2000","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.npep.2021.102160_bb0135","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s11418-015-0921-9","article-title":"Ninjin\u2019yoeito and ginseng extract prevent oxaliplatin-induced neurodegeneration in PC12 cells","volume":"69","author":"Suzuki","year":"2015","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.npep.2021.102160_bb0140","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s11418-017-1113-6","article-title":"Effect of ninjin\u2019yoeito and ginseng extracts on oxaliplatin-induced neuropathies in mice","volume":"71","author":"Suzuki","year":"2017","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.npep.2021.102160_bb0145","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0959-8049(05)80022-X","article-title":"Inhibition by shi-quan-da-bu-tang (TJ-48) of experimental hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats","volume":"30","author":"Tatsuta","year":"1994","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.npep.2021.102160_bb0150","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/ijc.23828","article-title":"Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress","volume":"123","author":"Tsuchiya","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.npep.2021.102160_bb0155","article-title":"Ninjin'yoeito modulates feeding and activity under negative energy balance conditions via the NPY system","volume":"102149","author":"Zhang","year":"2021","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2021.102160_bb0160","doi-asserted-by":"crossref","first-page":"104759","DOI":"10.1016\/j.fitote.2020.104759","article-title":"Polygalae Radix: a review of its traditional uses, phytochemistry, pharmacology, toxicology, and pharmacokinetics","volume":"147","author":"Zhao","year":"2020","journal-title":"Fitoterapia"}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417921000469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417921000469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:37:16Z","timestamp":1758919036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417921000469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":32,"alternative-id":["S0143417921000469"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2021.102160","relation":{},"ISSN":["0143-4179"],"issn-type":[{"type":"print","value":"0143-4179"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple stage IV colorectal cancers in a patient who received multidisciplinary treatment, including chemotherapy and Japanese Kampo medicine: A case report","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2021.102160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102160"}}